Save your place

Sign in to WhoBought

Please try again later.

Pliant Therapeutics, Inc. (PLRX) institutional ownership

Latest close $1.05 Jul 29, 2026
Market cap$97M 52-week range SectorHealthcare
Funds holding · Q1 2026
78
reported PLRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
37 buyers · 41 sellers

Pliant Therapeutics, Inc. (PLRX) price and institutional activity

Dates

Q1 2026

$0 bought by 37 investors
Adar1 Capital Management, LLCTwo Sigma Investments, LP +35 more
$0 sold by 41 investors
Two Sigma Advisers, LPRedmile Group, LLC +39 more
Bought Sold Totals per quarter; hover a bar for the names.

Pliant Therapeutics, Inc. (PLRX) institutional activity · 78

Investor Type Est. change Change Δ Own Date
Adar1 Capital Management, LLC · Added
Change +2.5M Date Q1 2026
Adar1 Capital Management, LLC Added· Q1 2026 +2.5M Q1 2026
Two Sigma Investments, LP · Added
Change +1.3M Δ Own +136.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.3M +136.4% Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.2M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.2M −100.0% Q1 2026
Redmile Group, LLC · Reduced
Change −844K Date Q1 2026
Redmile Group, LLC Reduced· Q1 2026 −844K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +807K +77.2% Q1 2026
Millennium Management LLC · Added
Change +772K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +772K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +643K +24.9% Q1 2026
Centiva Capital, LP · Reduced
Change −567K Date Q1 2026
Centiva Capital, LP Reduced· Q1 2026 −567K Q1 2026
Dafna Capital Management LLC · New
Change +487K Date Q1 2026
Dafna Capital Management LLC New· Q1 2026 +487K Q1 2026
Peapod Lane Capital LLC · Added
Change +402K Date Q1 2026
Peapod Lane Capital LLC Added· Q1 2026 +402K Q1 2026
Woodline Partners LP · Reduced
Change −359K Date Q1 2026
Woodline Partners LP Reduced· Q1 2026 −359K Q1 2026
Bank of America Corp · Reduced
Change −359K Date Q1 2026
Bank of America Corp Reduced· Q1 2026 −359K Q1 2026
JPMorgan Chase & Co · Reduced
Change −351K Date Q1 2026
JPMorgan Chase & Co Reduced· Q1 2026 −351K Q1 2026
Goldman Sachs Group Inc · Added
Change +320K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +320K Q1 2026
Jane Street Group, LLC · Reduced
Change −297K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −297K Q1 2026
Data through Q1 2026 · filed May 16, 2026
15 of 78

Famous investor activity in Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics, Inc. (PLRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Iannone Robert · Director Grant (A) 60K
Owned 60K Trade date Jul 9, 2026 Filed date Jul 13, 2026
Iannone Robert Director Grant (A) 60K 60K Jul 9, 2026 Jul 13, 2026
Borellini Flavia · Director Grant (A) 60K
Owned 60K Trade date Jul 9, 2026 Filed date Jul 13, 2026
Borellini Flavia Director Grant (A) 60K 60K Jul 9, 2026 Jul 13, 2026
Crowell Gayle A. · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Crowell Gayle A. Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
McCourt Thomas A. · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
McCourt Thomas A. Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
Krognes Steve E. · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Krognes Steve E. Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
Curnutte John T. · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Curnutte John T. Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
Huh Hoyoung · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Huh Hoyoung Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
Cline Darren S. · Director Grant (A) 70K
Owned 70K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Cline Darren S. Director Grant (A) 70K 70K Jun 11, 2026 Jun 12, 2026
Kuo Minnie · Officer 3 operations -245K
Owned 0 Trade date Apr 17, 2026 Filed date Apr 17, 2026
Kuo Minnie Officer 3 operations -245K 0 Apr 17, 2026 Apr 17, 2026
Kuo Minnie · Officer 3 operations 245K
Owned 55K Trade date Apr 17, 2026 Filed date Apr 17, 2026
Kuo Minnie Officer 3 operations 245K 55K Apr 17, 2026 Apr 17, 2026
Cummings Keith Lamont · CFO 7 operations -592K
Owned 0 Trade date Apr 17, 2026 Filed date Apr 17, 2026
Cummings Keith Lamont CFO 7 operations -592K 0 Apr 17, 2026 Apr 17, 2026
Cummings Keith Lamont · CFO 7 operations 592K
Owned 113K Trade date Apr 17, 2026 Filed date Apr 17, 2026
Cummings Keith Lamont CFO 7 operations 592K 113K Apr 17, 2026 Apr 17, 2026
Coulie Bernard · Director 7 operations -2.0M
Owned 0 Trade date Apr 17, 2026 Filed date Apr 17, 2026
Coulie Bernard Director 7 operations -2.0M 0 Apr 17, 2026 Apr 17, 2026
Coulie Bernard · Director 7 operations 2.0M
Owned 325K Trade date Apr 17, 2026 Filed date Apr 17, 2026
Coulie Bernard Director 7 operations 2.0M 325K Apr 17, 2026 Apr 17, 2026
Cheung Lily · Officer 3 operations -227K
Owned 0 Trade date Apr 17, 2026 Filed date Apr 17, 2026
Cheung Lily Officer 3 operations -227K 0 Apr 17, 2026 Apr 17, 2026
15 of 24
15 of 24 Sign in to continue to older insider transactions.

Pliant Therapeutics, Inc. (PLRX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 4.8M
% of shares outstanding 8.0% Filing date Jan 25, 2024
BlackRock Inc. 4.8M 8.0% Jan 25, 2024
Chi Advisors LLC 3.2M
% of shares outstanding 6.6% Filing date Feb 13, 2023
Chi Advisors LLC 3.2M 6.6% Feb 13, 2023
Redmile Group, LLC 3.2M
% of shares outstanding 5.3% Filing date Nov 14, 2024
Redmile Group, LLC 3.2M 5.3% Nov 14, 2024
Blue Owl Capital Holdings LP 3.0M
% of shares outstanding 4.9% Filing date Nov 14, 2024
Blue Owl Capital Holdings LP 3.0M 4.9% Nov 14, 2024
The Vanguard Group 3.0M
% of shares outstanding 4.9% Filing date Jul 29, 2025
The Vanguard Group 3.0M 4.9% Jul 29, 2025
Novartis Institutes for Biomedical Research, Inc. 2.2M
% of shares outstanding 4.4% Filing date Aug 31, 2022
Novartis Institutes for Biomedical Research, Inc. 2.2M 4.4% Aug 31, 2022
Citadel Advisors LLC 2.1M
% of shares outstanding 3.4% Filing date Feb 9, 2026
Citadel Advisors LLC 2.1M 3.4% Feb 9, 2026
Woodline Partners LP 2.0M
% of shares outstanding 3.3% Filing date Feb 17, 2026
Woodline Partners LP 2.0M 3.3% Feb 17, 2026
8 of 16

Pliant Therapeutics, Inc. (PLRX) ownership FAQ

Who owns PLRX?

78 reporting institutions disclosed PLRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.